Clal Biotechnology Financials
| CBI Stock | 37.80 1.40 3.85% |
Clal |
Understanding current and past Clal Biotechnology Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Clal Biotechnology's financial statements are interrelated, with each one affecting the others. For example, an increase in Clal Biotechnology's assets may result in an increase in income on the income statement.
Please note, the presentation of Clal Biotechnology's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Clal Biotechnology's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Clal Biotechnology's management manipulating its earnings.
Clal Biotechnology Stock Summary
Clal Biotechnology competes with Kamada, BioLine RX, Evogene, Bezeq Israeli, and Compugen. Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It operates as a subsidiary of Clal Industries and Investments Ltd. CLAL BIOTECHNOLOGY operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.| Foreign Associate | USA |
| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| ISIN | IL0011042806 |
| Business Address | Azrieli Center, Tel |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.cbi.co.il |
| Phone | 972 3 612 1616 |
You should never invest in Clal Biotechnology without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Clal Stock, because this is throwing your money away. Analyzing the key information contained in Clal Biotechnology's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Clal Biotechnology Key Financial Ratios
Clal Biotechnology's financial ratios allow both analysts and investors to convert raw data from Clal Biotechnology's financial statements into concise, actionable information that can be used to evaluate the performance of Clal Biotechnology over time and compare it to other companies across industries.Clal Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Clal Biotechnology's current stock value. Our valuation model uses many indicators to compare Clal Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Clal Biotechnology competition to find correlations between indicators driving Clal Biotechnology's intrinsic value. More Info.Clal Biotechnology Industries is rated fifth in return on equity category among its peers. It is rated fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Clal Biotechnology by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Clal Biotechnology's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Clal Biotechnology Systematic Risk
Clal Biotechnology's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Clal Biotechnology volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Clal Biotechnology correlated with the market. If Beta is less than 0 Clal Biotechnology generally moves in the opposite direction as compared to the market. If Clal Biotechnology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Clal Biotechnology is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Clal Biotechnology is generally in the same direction as the market. If Beta > 1 Clal Biotechnology moves generally in the same direction as, but more than the movement of the benchmark.
Clal Biotechnology Thematic Clasifications
Clal Biotechnology Industries is part of several thematic ideas from Computers to IT. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasClal Biotechnology November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Clal Biotechnology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Clal Biotechnology Industries. We use our internally-developed statistical techniques to arrive at the intrinsic value of Clal Biotechnology Industries based on widely used predictive technical indicators. In general, we focus on analyzing Clal Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Clal Biotechnology's daily price indicators and compare them against related drivers.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 17.01 | |||
| Value At Risk | (5.59) | |||
| Potential Upside | 4.58 |
Complementary Tools for Clal Stock analysis
When running Clal Biotechnology's price analysis, check to measure Clal Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clal Biotechnology is operating at the current time. Most of Clal Biotechnology's value examination focuses on studying past and present price action to predict the probability of Clal Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clal Biotechnology's price. Additionally, you may evaluate how the addition of Clal Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |